ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000665.1|Xiamycin_1 # 1 # 1002 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.726	BGC0000665.1|Xiamycin_1 	1	1002	+	Loose	500	28.1054	OXA-75	43.75	3001620	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGACTGATGTGAGCTCGGATACGTACGCGGGCAGCGGGGTACGCCGTCGCGTCCTGCTGGCCGGTCCCCGGTCCTTCTGCGCGGGTGTCGAACGGGCCATCGAGATCGTCGAGCGGGCGCTGGAATCCCGCGGCGCCCCCGTCTACGTCCGCAAGCAGATCGTGCACAACGTCACCGTCGTCGACGATCTGGCGGATCGTGGCGCGGTGTTCGTCGACGAACTGGACGAGGTGCCCGACGGCTCGACGGTGGTCTTCTCCGCACACGGGGTCTCGCCCGCGGTGCGCGACGAGGCGGCCCGGCGCGGTCTGGAGGTGATCGACGGAACCTGTCCCCTGGTCGCCAAGGTGCACGCGGAGGCGCGCCGTTTCGCCGCCCGGGGCGACACCGTCGTCCTCGTGGGGCACGCCGGACACGAGGAGGTCGAGGGCACCATGGGCGAGGCGCCCGGGTCCATGGTGCTGGTCGAGACGGCGGAGGAGGCGCGCGCGCTCCCGACGGCCGACGGGCGGGCCGTGTCGTACCTCACCCAGACCACGCTGGCCGTCGACGAGACCGCGGAGGTCGTCGGGGCGCTGCGGGAGACGTTCCCGCTGCTCCAGGAGCCGCCGTCGGACGACATCTGCTACGCCACCACCAACCGGCAGGCCGCGCTCTCGGCGATCGTCGCGGAGTCGGACCTCGTCCTGGTCGTCGGGTCGGAGAACTCCTCCAACTCGGTACGGCTGGTGGAGATGGCGCGCCGCGGGGGCACCCGGGCCGAGCTGATCGACCGGGCCGCGGACATCCCCGAGGAGTGGCTGGACGGGGTGCGGACGGTGGGGCTGACGGCCGGCGCCTCGGCGCCGCCCGCCCTGGTGACGGAGGTGGTGACGTGGCTGAAGGGCTTCGGCCCGGTCGACGTCGAGGAACGCGAGATCACTCGCGAAGACATACATTTCGACCTTCCCTCGGCGGTACGCGCTCGGCCGCGTCCGCCGGCGGACGGCCGCCCCAGCTGA	VTDVSSDTYAGSGVRRRVLLAGPRSFCAGVERAIEIVERALESRGAPVYVRKQIVHNVTVVDDLADRGAVFVDELDEVPDGSTVVFSAHGVSPAVRDEAARRGLEVIDGTCPLVAKVHAEARRFAARGDTVVLVGHAGHEEVEGTMGEAPGSMVLVETAEEARALPTADGRAVSYLTQTTLAVDETAEVVGALRETFPLLQEPPSDDICYATTNRQAALSAIVAESDLVLVVGSENSSNSVRLVEMARRGGTRAELIDRAADIPEEWLDGVRTVGLTAGASAPPALVTEVVTWLKGFGPVDVEEREITREDIHFDLPSAVRARPRPPADGRPS	MNIQALLLITSAIFISACSPYIVTANPNYSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTLGDAMKASAIPVYQDLARRIGLELMSNEVKRIGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGISSSVRKEITYRGLEQLGIL	121.53	gnl|BL_ORD_ID|478|hsp_num:0	523			711	807	cloxacillin; oxacillin; cefalotin
BGC0000665.1|Xiamycin_2 # 1015 # 2832 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.740	BGC0000665.1|Xiamycin_2 	1015	2832	+	Loose	500	26.5646	STA-1	32.56	3007000	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	STA beta-lactamase	GTGTCATTCTCTGTGCTCGGCCGGATCACCGGCTCCGAGGACCTCAAAGGGCTGCACCCGGACCAACTGCCCGCCCTGGCGGGCGAGATCCGGGACTTCCTGATCGAGAAGGTGTGCGCGACCGGCGGACACCTCGGTCCGAACCTCGGTGTGGTGGAGCTGACCATCGCGCTGCACCGGGTGTTCGACTCCCCCGTGGACCGCGTGGTGTTCGACACCGGCCACCAGTCCTACGTCCACAAGCTGCTCACCGGCCGGCAGGCCGCCTTCGACTCGCTGCGCGCGGCCGGGGGCCTGTCCGGCTACCCCCTGCGCGAGGAGTCCGAGCACGATCTGGTGGAGAACTCGCACGCCTCCACCGCGCTGTCCTACGCGGACGGCCTGGCCAAGGCCCAGCGGCTGCTCGGTGAGGACCACCGCCGCGTGGTCGCGGTCACCGGGGACGGCGCGCTGACCGGCGGCATGGCCTGGGAGGCGATGAACAACCTGGGCAGCGGCGGCGGTTCGGTGATCGTCGTACTCAACGACAACGGCCGCTCCTACGATCCCACCGTCGGTGGGCTGGCCGAGCACCTGACCGCCCTGCGGGCCGGTTCCCACCAGGGGCCCAACCTCTTCGAGACCATGGGCTTCGCCTACCTCGGTCCGGTGGACGGGCACGACGTCGCCGCCGTCGAGGAGGCGTTCCGCCGGGCGGCGGGGCTGACCGGCCCGGTCGTCGTCCACTGCGTCACCGAGAAGGGCCGGGGGTACGTCCACGCCGAGAACGACGAGGCCGACCGCATGCACGGCATCGGCGTCGTCGACTCCGCCACGGGCCTTCCGCGGGGCGGCGGTTCGCCCTCGTGGACGGGCACCTTCGGCTCGGAGATGGAGCGGATCGGCGCGAGGCGTCCCGACGTCGTCGCGCTGACCGCGGCGATGCTGCGGCCGGTCGGACTGCACCGGTTCGCCCGGAGCTTCCCGGACCGGGTCTTCGACACCGGCATCGCCGAGCAGCACGCGGTCACCAGTGCCGCGGGGATGGCCATGGCCGGGCTGCACCCCGTGGTGTGCCTGTACGCCACGTTCCTCAACCGGGCCGTGGACCAGGTCATGATGGACGTGGCCCTGCACGGGCTGCCGGTGACCTTCGTCCTGGACCGGGCGGGCGTCACCGGTCCCGACGGTCCCAGCCACCACGGCATGTGGGACCTCTCCCTGCTGGGCACGGTGCCGGGCATGCGGGTCGCCGCGCCCCGGGACCCCGCCCGCCTCACGGAACTGCTGGAGGAGGCGCTGGACATCGGGGACGGCCCCACCGCGCTGCGCTTCCCGAAGGGCGGCGCGGGGCCGGAGATCCCGGCGCTGGGCCGGATGCAGGGCCTGGACGTACTGCACCGCACCCGGTCACGGCCGCTGGACGTGCTGCTCGTCAGCGCCGGGGTGCTCGCGGGTACGGCGCTGGGCGCGGCGGAGCTGCTCGCCGCCGAGGGCGTCGGGGTCACGGTCGTCGACCCGCGCTGGGTCCTGCCGGTCTCCCCCGACCTGGTCCATCTGGCCGCCCGGCACCGGCTGACCCTGTCCGTCGAGGACGGGGTGCGTGCCGGCGGGGTGGGCGCCGCCCTGGCACAGGCGTGCGCCGATGCCCGGGTGCCGGCGCCGGTGCACGCCCTGGGGCTGCCGCACGCCTTCCTCGACCACGGCGAGCGGCCGGACATCCTCGCCGAACACGGCCTCACCGCGCGGTCCGTCGCCGACACCGCGCTCGCGCTGCACCATGCCGCGGCGCCATCCCCCACACCACCGGCACCCCGTCGGGAGAGGACTCCACGGTGA	MSFSVLGRITGSEDLKGLHPDQLPALAGEIRDFLIEKVCATGGHLGPNLGVVELTIALHRVFDSPVDRVVFDTGHQSYVHKLLTGRQAAFDSLRAAGGLSGYPLREESEHDLVENSHASTALSYADGLAKAQRLLGEDHRRVVAVTGDGALTGGMAWEAMNNLGSGGGSVIVVLNDNGRSYDPTVGGLAEHLTALRAGSHQGPNLFETMGFAYLGPVDGHDVAAVEEAFRRAAGLTGPVVVHCVTEKGRGYVHAENDEADRMHGIGVVDSATGLPRGGGSPSWTGTFGSEMERIGARRPDVVALTAAMLRPVGLHRFARSFPDRVFDTGIAEQHAVTSAAGMAMAGLHPVVCLYATFLNRAVDQVMMDVALHGLPVTFVLDRAGVTGPDGPSHHGMWDLSLLGTVPGMRVAAPRDPARLTELLEEALDIGDGPTALRFPKGGAGPEIPALGRMQGLDVLHRTRSRPLDVLLVSAGVLAGTALGAAELLAAEGVGVTVVDPRWVLPVSPDLVHLAARHRLTLSVEDGVRAGGVGAALAQACADARVPAPVHALGLPHAFLDHGERPDILAEHGLTARSVADTALALHHAAAPSPTPPAPRRERTPR	MHPPLRPHPLWCSLRPATLALLLGVFGCRTSVPAPRPAAEPFTSITEDLRIQPLAPGVWRLVALSGEEWGHIPANGLVIAEGGGVLLVDPGWTEAQGERLLQWVEDTLKVPVHAGVATHFHADRTGGLRALQARGIPTHALALTAALTSQQDRPAPTHLFPGPAQQLGPVELFFPGPGHAPDNITVWHAASGILFGGCMVKDLKASSLGNLSDADLASWPRSVESLQARYPAARTVIPGHGEPGDTSLLAHTLELLRAGSR	231.80	gnl|BL_ORD_ID|4596|hsp_num:0	5666			228	462	
BGC0000665.1|Xiamycin_3 # 2922 # 3980 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0000665.1|Xiamycin_3 	2922	3980	+	Loose	600	25.409	vanS gene in vanP cluster	27.87	3007192	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGGGCAGTGACCATCCCGTGTCGGTGCAGTCGATGACGACGACCGTCACGGCCGACGTCAACGCCACCCTCCAGCAGATCGCCGAACTCACCGCCGCGGGCTGCGACATCGTGCGGGTCGCCTGCCCGAGCGCGGACGACGCCGAGGCGCTGCCCGCGATCGCCCGCAAGTCGAAGATCCCGGTGATCGCCGACATCCACTTCCAGCCGAAGTACGTCTTCGCGGCGATCGAGGCCGGCTGTGCGGCGGTGCGGGTCAACCCGGGCAACATCAAGAAGTTCGACGACAAGGTGGGCGAGATCGCCCGCGCCGCCAAGGACCACGGCACCCCGATCCGGATCGGGGTGAACGCCGGGTCGCTGGACGCGCGCCTGATGCGCAAGTACGGGAAGGCCACTCCGGAGGCGCTGGCCGAGTCGGCGCTGTGGGAGGCGTCGCTCTTCGCCGAACACGACTTCCACGAGCTGAAGATCTCGGTCAAGCACAACGACCCCGTGGTCATGATCCGCGCCTACGAGATCCTCGCCGAGCAGTGCGACTACCCGCTGCACCTGGGCGTCACCGAGGCGGGGCCGGCGTTCCAGGGCACCGTCAAGTCCGCCGTGGCCTTCGGGGCGCTGCTGCGCCAGGGCATCGGCGACACCATCCGGGTCTCCCTCTCGGCGCCGCCGGTGGAGGAGGTCAAGGTCGGCGCGCAGATCCTGCAGTCGCTCAATCTGCGGCCCCGCAAGCTGGAGATCGTCTCCTGCCCCTCGTGCGGCCGGGCGCAGGTGGACGTCTACAAGCTCGCCGACGAGGTCACCGCCGGCCTGGAGGGCATGGAGGTGCCCCTGCGGGTCGCCGTGATGGGGTGCGTGGTCAACGGCCCCGGCGAGGCGCGCGAGGCCGACCTCGGAGTGGCGTCCGGCAACGGCAAGGGGCAGATCTTCGTCAAGGGCGAGGTCGTCAAGACCGTCCCCGAGTCAAAGATCGTCGAGACCCTCATCGAGGAGGCGCTGAGCCTCGCCGAGACGATGGACGAGCAGGCAGGAGGCTCCGTCACGGTCGTCACCGGTTGA	MGSDHPVSVQSMTTTVTADVNATLQQIAELTAAGCDIVRVACPSADDAEALPAIARKSKIPVIADIHFQPKYVFAAIEAGCAAVRVNPGNIKKFDDKVGEIARAAKDHGTPIRIGVNAGSLDARLMRKYGKATPEALAESALWEASLFAEHDFHELKISVKHNDPVVMIRAYEILAEQCDYPLHLGVTEAGPAFQGTVKSAVAFGALLRQGIGDTIRVSLSAPPVEEVKVGAQILQSLNLRPRKLEIVSCPSCGRAQVDVYKLADEVTAGLEGMEVPLRVAVMGCVVNGPGEAREADLGVASGNGKGQIFVKGEVVKTVPESKIVETLIEEALSLAETMDEQAGGSVTVVTG	MNKRLKKSISRYFFIRFLQGLCCMSFFLVFALGISYLWCSERVWYEGEVSYFIVHILHEYWYVLFLGLMIIGCIVIAMINIRCIAQGISDIMQAVRDVNEENEVQIELPDYLADAQAQLTDIKNHVEWNKKTAQEAVQRKNDLIMYLAHDLKTPLTSTIGYLTLLHDEKEISKEVRDKYMGIALKKSLRLEELLNEFFEIARFNFSTMVLEKGNVNMSVMVEQLLYEFKPLFDKKGLTYTIDLEKDVNVYCDVEKMERVFDNLLKNIVNYSYENTEIAITLKANGEQGMLFVIRNHGKTIPKEKCERIFEQFYRLDGSRGTKTGGSGLGLAVVKEIVELHEGTVTCESENEEICFRITI	98.05	gnl|BL_ORD_ID|4822|hsp_num:0	5808			798	978	vancomycin; teicoplanin
BGC0000665.1|Xiamycin_4 # 4078 # 4386 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.683	BGC0000665.1|Xiamycin_4 	4078	4386	+	Loose	700	24.2534	vanS gene in vanC cluster	44.44	3002933	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGACCACTGAAGGCCACTTTCGGGGAGCTTTGACGTGCTTGCCGTACACGCGCTTGACGTACCCGTGCCTGCCGTACCAGTGCTTGCAGTACCCGTGGTTGCCGTACCCGTGGTTGCCGTACCCGTGCCTGACGCACAGGCGCTCGCCGTACACGGGGCACCACTGGACGCGTCCCTCGGCGGTCCGTCCGCCCGGCCCTGTTGCTGACCGGGCCGGCCGCACGGACGGAGAAAGAAGCACAGCGATCACCGGCTCGGGCACCGCCATGCCCGGAACCGGCCTCGGGACGGACATGCTCCGGCCATAG	MTTEGHFRGALTCLPYTRLTYPCLPYQCLQYPWLPYPWLPYPCLTHRRSPYTGHHWTRPSAVRPPGPVADRAGRTDGERSTAITGSGTAMPGTGLGTDMLRP	MKNRNPLIRKLLTQYFVTTGILLAFLVMIPLVIRFIAGTRTWYGTEPIYYILRFFADRWLFCVAIGALLIWFGTTIYYMTKAIGYLNETIQATTQLIEEPSKRITLSSHLIDVQEEMNQLREKSLQDQRAAKEAEQRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPQLSNAMRNRYTEIALQKAQRLELLISEFFEITRFNLTTIVLQTETTDLSLMLEQLTFEFLPLLEEKNLNWQLNLQKNVLATVDTEKIARVFDNLIRNAINYSYPDSPLLLELVESDSIHIRLTNRGKTIPEEMIGRLFEPFYRMDSSRATATSGTGLGLPIAKEILLASGGDISAESKDETIIFNVRLPKPANN	28.25	gnl|BL_ORD_ID|904|hsp_num:0	966			927	981	vancomycin
BGC0000665.1|Xiamycin_5 # 4412 # 5134 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0000665.1|Xiamycin_5 	4412	5134	+	Loose	470	35.4242	sdiA	27.87	3000826	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACTGCCAACACCCAGACGGAGAAAACCGGGCCGCTCCCCACCGGGACGCGGACCACGAGGACGCAGACCGCCGGAGAGAACCCCGCCAAGGCCGCGATCCGGCCGGCGAAGGTCCTGGTCAGGGCACCGGATCCGCTGACGCACTCGGCGATCAGCGGTCAGCTCGCCACCGCGCCGGGCATAGAAGTGGTCGCGGTGGGGAGCACCGGCCCGGCCGACGTGGCCGTGTTCGTCACCGAGCGCCTGACCGTGGACGTCACCTCGACCCTGCGCAGGCTGAAGAGCTCCTTACGGATACCGGTGGTGCTCATCCCGTCGCAGATCGACCGCGCGGACCTCTTCACCGCGGTGGAGTGCAACGTGGTCGCGGTCCTGCCGCGGGTCGCCGCCACCAGCGAGCGCATCCGGGAGACGGTGCTGACCGCCGCGTCCGGCGGTGGCGTGCTCCCCACGAAGCTGCTGGGCGAACTGCTCCGGCAGTTCGAGTGGATGCAGCGCGAGGTCCTGTCACCGCACGGCCTGCACACCTCCGGGCTGACTCCCCGGGAGATCGACGTCCTGCGGCTGATGTCGGAGGGGCTGGACACCGCCGAGATCGCCGTCCGGATGTGCCTGTCGGAACGGGCGGTCAAACGGGTCGTCTTCGGGGTCACCCAGCGCCTCAACCTGCGCAACCGGCCGCACGCGGTGGCCTACGCCCTACGCAGTGGCGTCATCTGA	MTANTQTEKTGPLPTGTRTTRTQTAGENPAKAAIRPAKVLVRAPDPLTHSAISGQLATAPGIEVVAVGSTGPADVAVFVTERLTVDVTSTLRRLKSSLRIPVVLIPSQIDRADLFTAVECNVVAVLPRVAATSERIRETVLTAASGGGVLPTKLLGELLRQFEWMQREVLSPHGLHTSGLTPREIDVLRLMSEGLDTAEIAVRMCLSERAVKRVVFGVTQRLNLRNRPHAVAYALRSGVI	MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI	100.00	gnl|BL_ORD_ID|207|hsp_num:0	228			537	720	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000665.1|Xiamycin_6 # 5127 # 5879 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0000665.1|Xiamycin_6 	5127	5879	-	Loose	500	25.0238	bcr-1	28.99	3003801	protein homolog model	n/a	n/a	bicyclomycin-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGTCTGGCTGCCCCCCTTTCTCATCCCGATGTCGGAGGTCCCGCCCGTGACGGTGGGGGCGGCCGACGTCTCGGACCTGCTCTTCGCGGCCGTCGCCGGACCGACCGCGCTGGGCTGGATGGTGACGTACGTCCTGGCGATCCGGCAGGCCCGCCGGGACGGGCGCACGGGGATACCCGCGTACCTCATCGCGGTGAACATCGCCTGGGAGTTCAGCCTGACCTTCCTGCTGGAGCAGACACCGACCCAGCGGCAGATCAACTTCCTGTGGCTGGTCTTCAACGTCTTCCTGTTCGCCCAGGCCCTGCGGTACGGGCCGCGCGACTACCCCGGCCTCTCCGCGCGCACCTTCCGGTGGACGCTCGCCGGTGTGCTGGTGTGGGCGTCGGTCGTCGTCATGGTCGGCGCCAACGAGCTGCACGACGTCGACGGCATGTACACCGGCATGATCATCCAGGTGCCGCTGAGCGCCGCGTTCATCCTCATGCTCAGGCGGCGCGGATCCAGTGCGGGCCAGTCGATGCACATCGCGGTCGCCAAGACCGTGGGGTCCCTCTTCGCCGGCCTGACCGCCGTGATCGTCTATCCCTCCCACCACCTGCTGCAGGTGCTGGTGCCGACCTACGTCGTCCTGGACGTCGCCTACGTGGTGCTGCTGCGCCGGACGATGCTCCGCGAGGGACGGCCGCTGTGGGCCTTCCGCCACCCGGGCGCCGGTGTCCCGGGCGGGTGCCGGCTCCCGGTCAGATGA	MVWLPPFLIPMSEVPPVTVGAADVSDLLFAAVAGPTALGWMVTYVLAIRQARRDGRTGIPAYLIAVNIAWEFSLTFLLEQTPTQRQINFLWLVFNVFLFAQALRYGPRDYPGLSARTFRWTLAGVLVWASVVVMVGANELHDVDGMYTGMIIQVPLSAAFILMLRRRGSSAGQSMHIAVAKTVGSLFAGLTAVIVYPSHHLLQVLVPTYVVLDVAYVVLLRRTMLREGRPLWAFRHPGAGVPGGCRLPVR	MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGFLVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGAASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFAGLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAAPFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFLLGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLGCLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR	62.19	gnl|BL_ORD_ID|2332|hsp_num:0	2303			849	1029	bicyclomycin
BGC0000665.1|Xiamycin_7 # 5946 # 7139 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000665.1|Xiamycin_7 	5946	7139	-	Loose	300	28.4906	AAC(3)-VIIIa	39.13	3002542	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGACAGACATCCGATCGGAGACGGCGGAACTGCGGGCCGAACTCGTGGAGAGGGTCCACAAGTTCGGCCCGGTCTTCGCGGACGGCGTCGCCGAGGGGGAGCGGGAGCGACGGCTGCCCGACGCCACGGTCCGCGCCATCGACCAGTCCCAACTGGCCATGCTGTGGACCGCGAAGTCCTACGGCGGCCTGGAGACCGACGTGCGGACCATGAGCGAGGTGGCCAAGGTCCTCTCCCACTACTGCCCGTCCACCTCCTGGGTGGTCAACAACGTCAACGGCTCCAACCTGCTCGCCTCGAAGTTCCCGCGGGCGGCGCTGGACGAGGTGTTCGGGGACGCCCCCGGCGCCAAACTGGCGTCGGTCTTCGCGGCCGCGGGCACAGCGGTACGCACCCCCGGCGGCTACCGGCTGACGGGCTCCTGGCCGTACGGCACCGGCATCCTGCACGACGACTGGGCGATCCTGGTCGCGCGGGAGGTGGACGCCGACGGGGAGCCGGTCGGCGGGCTCTCCATGCTGGTGCCGGCCCGGGACCTGACCGTCGAGGACACCTGGCACACCGTCGGCATGCGGGCCACCGGCAGCCACACCGTCGTCCTGCGGGACACGTTCGTCCCCGAACACCGGGTGATCAGCGGCGAGTTGCAGCGCAGCCGGGAGAGCGCCACCGACCTCGGCCTGCCACCCCTGTTCCGTACGGCGGCGATCGCCGCCATGGCCGTCGTCTGCGCCTCCGTGGTGCTCGGCGCCGGCCAGGCGGCCCGCGCCCTCGTCGTGGAGAAGGCGCCGACGCGGGGGATCGCGCCCTCCAAGTACACCCGTCAGACGGACTCACGGACGTTCGTGTCCTCGCTCGGCCGCACCGCCCTGTCGATCGACGCCGCCGAGATGCACGTGGCACGGGCCGCGACCGCCCTCGACGACGCCGCGTACGACGCCGTCGCGCTGCCGGACAGCGAACTCCTGCGCATCCGCGGCGACGTGGGCCAGGCGGTGAGCCTGGTGACCACCGCCCTCGACGAACTGCTGTGGGCCCACGGGGCGGCGTCCTTCGCCGAGTCGAACCCGCTGCAGCGGTACTGGCGGGACGCCAACACCGCGGCCCGCCACGCGATGCTCAACGTGCACGTCGGCCACGAGCTGTACGGCGGTTCCTTCTTCGGTCTCGACCCCATCGTGCCCAGCCTCTGA	MTDIRSETAELRAELVERVHKFGPVFADGVAEGERERRLPDATVRAIDQSQLAMLWTAKSYGGLETDVRTMSEVAKVLSHYCPSTSWVVNNVNGSNLLASKFPRAALDEVFGDAPGAKLASVFAAAGTAVRTPGGYRLTGSWPYGTGILHDDWAILVAREVDADGEPVGGLSMLVPARDLTVEDTWHTVGMRATGSHTVVLRDTFVPEHRVISGELQRSRESATDLGLPPLFRTAAIAAMAVVCASVVLGAGQAARALVVEKAPTRGIAPSKYTRQTDSRTFVSSLGRTALSIDAAEMHVARAATALDDAAYDAVALPDSELLRIRGDVGQAVSLVTTALDELLWAHGAASFAESNPLQRYWRDANTAARHAMLNVHVGHELYGGSFFGLDPIVPSL	MDEKELIERAGGPVTRGRLVRDLEALGVGAGDTVMVHTRMSAIGYVVGGPQTVIDAVRDAVGADGTLMAYCGWNDAPPYDLAEWPPAWREAARAEWPAYDPLLSEADRGNGRVPEALRHQPGAVRSRHPDASFVAVGPAAHPLMDDHPWDDPHGPDSPLARLAGAGGRVLLLGAPLDTLTLLHHAEARAEAPGKRFVAYEQPVTVGGRRVWRRFRDVDTSRGVPYGRVVPEGVVPFTVIAQDMLAAGIGRTGRVAAAPVHLFEAADVVRFGVEWIESRMGGAAGGA	138.81	gnl|BL_ORD_ID|461|hsp_num:0	501			387	588	neomycin
BGC0000665.1|Xiamycin_8 # 7142 # 7531 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.708	BGC0000665.1|Xiamycin_8 	7142	7531	-	Loose	2000	27.7202	adeJ	26.51	3000781	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCTCGACCGACGGCGAGCGCCTCGTCCACACCTTCCTGACATCGATGGGGCCGACCCCGGCCGACGTCCGCACGGCCGTGGAGACCCACCTCACCGACGACTGCGTGTGGGAGAACCCCGGCTCCCCGGTGTGCCGGGGCAAGGCGGAGATCCTCCGGCTCATGCCGCCCGACTTCGCGCGCCTGAAGGTGAGGTTCGGGCACCTGGCCACGGCCGGGGAGACCGTCCTCGTCGAACGCCTGGAGGACATGCTCCGCGCCGACGGCACCCACATCGCGCGCAACCTGAAGGTGATGGGCGCCTTCGACCTGCGGGCCGGACGGATCCGCGCCTGGCGGGACTACTTCGACCACACCCACCTCATCACCGACAGCCCGGAGTGGTGA	MPSTDGERLVHTFLTSMGPTPADVRTAVETHLTDDCVWENPGSPVCRGKAEILRLMPPDFARLKVRFGHLATAGETVLVERLEDMLRADGTHIARNLKVMGAFDLRAGRIRAWRDYFDHTHLITDSPEW	MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS	12.19	gnl|BL_ORD_ID|574|hsp_num:0	630			576	807	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
BGC0000665.1|Xiamycin_9 # 7534 # 9324 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.749	BGC0000665.1|Xiamycin_9 	7534	9324	-	Loose	600	99.7525	Streptomyces venezuelae rox	32.64	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGTTCGACGTAGAAGTGCCGGTCCTCGTGGTCGGCGGCGGTGGCTGCGGGCTCGCCGCGTCGGTGTTCCTGTCCGACGTCGGGGTGCGGCACCTGGTGGTGGAGCGGCGCGAGTCGACGTCCGTCCTGCCCAGGGCGCACTACCTGAACCAGCGCACCATGGAGGTGTTCCGCCAGCACGGCGTCGCCGACGACGTGTACGGGATCAGCTGCCCGCTGCCGAACATGAGCGAGATCGCCTGGCGCACCTCGCTCGGCGGCGACGGTCCCGCGGACGGGCGTGAACTGCACCGGATGGAGGCCTTCGGGGGAGGCGGCACCGCCGGACCCTACGCCGCCCACAGCACCGGGCCCTCCACCAACCTCCCGCAGCACCGGCTCGAACCGCTGCTGCGCCGGCACGCGGAGCGCCGGGCGCCCGGAAGCCTGCTCTTCCACCACCAGATGGAGGAGTTCACGCAGGACGAGCACGGGGTCGTGGCCCGGGTGACCGACCGGAGCACCGGCGAGGTGGGCACCGTACGCGCCCGGTACCTGCTGGGAGCCGACGGCGGCCGCGGCGTCGGGGACGCGCTCGGCATCCGGATGGACGGCGCGGGCGGCGCCTTCACCATCATCTCCGTGCACTTCAGCGCCGACCTCTCCCGCTGGTGGAGCGACCCGGTGCTGATGACGCACATCTTCGGCCTCGACGGCGAGGTCTCGGTACTCGTCGCCTCCGGGCCCGACTGGGGTGCCGCGTCCCAGGAGTGGGCCCTGCACTTCCGGGTGCCGCCCGGCACGGCGGCGGGCGGCCTCGACGCGGACACGATCACGGGCCGCGTCCGGGAGCTGCTGAAGCTGCCCGCGGACCTCGGGGTACGGATCCACCACGTGAGCGAGTACCGGCCGGAGGCGGTCGTGGCCCGCTCGTTCCGCTCCGGCCGCGTCTTCCTCGCCGGTGACGCGGCACACCGGCAGCCGCCCGCCGCGGGCGGCGGCCTCAACACGGCGATCCAGGACGTCCACAACCTCGCCTGGAAGCTCGGGGCCGTGCTGGAGGGCCGGGCCGGCGACGCGCTGCTCGACTCCTACGAGGCGGAGCGGCTGCCCGTCGCCCGGCGCAACGTCGGCTGGGCGATGGGCTGTCTGCTCAACTACGGTTCCCTCTTCGCGGCCCTCGGCATGGCGCACGGGAAACCGGAGGCCACCGAGGCCAGTATCCGCGAGCTCCTCGCCGACACCCCGATGGGCGAGACCCGGCGGTCCGTGGTCCGGGAGGTGTTCGGCACCCAGCGCATCGAGTACCAGGCACACGACATCGAGCTCGGCCACCACTACGCCTCCGGCGCCGTCGTCGCGGACGGCACCCCGCCGCCGCCCCGCGACCCGTGGGGCGCGGTGCACCACCCGACGACCCGCCCGGGGCACCGGCTCCCGCACGTGTGGCTGCGGGACGGCGACGCCCGGCACTCCACGCACGACCTGGTCCCCGGCGACGGCGGTTTCCTCCTGCTCACCGGTCCGCTGGGCGAGGGCTGGGCGGCGGCCGCCAAGAAGGCCGCCGCCGACCACGGGGTGGCGATCACCGTGGTGCCCGTCGGCGGCGAACCCGGCGCGGCGGGCCACCGGGACACCGAGGGCGCCTGGACCGGGGTGCGGGGCGTCGACGACGACGGCGCCGTTCTCGTACGGCCCGACCAGCACGTCGCCTGGCGCAGCGTGCGGGGCAGCCGCCGCGCCGACCACGAACTGGGCGAGGTCCTCGACACCGTGCTCGGCCGCTCCGGCGCGGCGAACGGCGGGTGCTGA	MFDVEVPVLVVGGGGCGLAASVFLSDVGVRHLVVERRESTSVLPRAHYLNQRTMEVFRQHGVADDVYGISCPLPNMSEIAWRTSLGGDGPADGRELHRMEAFGGGGTAGPYAAHSTGPSTNLPQHRLEPLLRRHAERRAPGSLLFHHQMEEFTQDEHGVVARVTDRSTGEVGTVRARYLLGADGGRGVGDALGIRMDGAGGAFTIISVHFSADLSRWWSDPVLMTHIFGLDGEVSVLVASGPDWGAASQEWALHFRVPPGTAAGGLDADTITGRVRELLKLPADLGVRIHHVSEYRPEAVVARSFRSGRVFLAGDAAHRQPPAAGGGLNTAIQDVHNLAWKLGAVLEGRAGDALLDSYEAERLPVARRNVGWAMGCLLNYGSLFAALGMAHGKPEATEASIRELLADTPMGETRRSVVREVFGTQRIEYQAHDIELGHHYASGAVVADGTPPPPRDPWGAVHHPTTRPGHRLPHVWLRDGDARHSTHDLVPGDGGFLLLTGPLGEGWAAAAKKAAADHGVAITVVPVGGEPGAAGHRDTEGAWTGVRGVDDDGAVLVRPDQHVAWRSVRGSRRADHELGEVLDTVLGRSGAANGGC	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	125.21	gnl|BL_ORD_ID|4833|hsp_num:0	5820			0	984	rifampin; rifaximin; rifapentine
BGC0000665.1|Xiamycin_10 # 9324 # 9557 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.705	BGC0000665.1|Xiamycin_10 	9324	9557	-	Loose	1280	25.7942	macB	36.84	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAAGATCGAGGTCGACGACACCAGGTGCTTCGCCGTCGGCAACTGCGCCCTGCACGCGCCGGCGGTCTTCGACCAGAACGACGAGGACGGCAGGGTGGTCGTACTCGACCCCGCCCCGTCCGAGCAGCAGTACGCACAGGTCCGGGAGGCGGCCTCGCGGTGTCCGGCCGCGGTCATCGTCCTGCACGAGGACGCCCCGGACCGGCCCGGCACAATCCCGAGGGAAGAGTGA	MKIEVDDTRCFAVGNCALHAPAVFDQNDEDGRVVVLDPAPSEQQYAQVREAASRCPAAVIVLHEDAPDRPGTIPREE	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	11.96	gnl|BL_ORD_ID|446|hsp_num:0	487			1119	1233	erythromycin
BGC0000665.1|Xiamycin_11 # 9583 # 10752 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0000665.1|Xiamycin_11 	9583	10752	-	Loose	300	29.261	catS	36.36	3002688	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGACCGAGCCGAAGACCGTCCCCATCGGCGGACGGGCCGCCCAGTGCCCGTTCGCCCCCGTCGCCGAGCTGTACGACACGCAGAAGGAGGACGAGCTCAGCCGCGTCAAGGTGCCCAGCCCGATGCTGGGCGAGTTCGACGCGGTGCTCGTCACCCGGTACGACGACGTCAAGGACGTACTCGCCGACGAGGGCCTGCGGATGGGCGGCTCCATGCCGTACCAGCCCGGCAACCTGCTGAGCTACGACGGCCCCGAACACACCAAACTGCGGCGGATGCTGACCGCGTCGTTCACCACCAAACGGGCGCGCGAGCTGCGGCCGGGCATCGAGGCCGTGGTCGCGTCCTCGCTGGACGCGGTCGAGGAGGCCGGTCCGGGCGCCGACCTGGTGCAGCTCTTCAGCACCCCGATCCCGACGCTCGTCATCTGCGAACTCCTCGGCGTGCCCTACACCGACCGCGAGGGCTTCCAGCGCCGTACCGCCCTCGCACTGGACTTCACCCAGAGCCGCGAGGTCCAGATGGAGAAGGCCGCCGAGATGATGGCCTACATGGCCCAACTCGTGGCCCGGCACCGGGAGAACGCGGGCGACAACGTGCTGGGCCGCGTGGTGCGCGAGTACGGCGACCAGCTGAGCGACGAGGAGCTGGCCGGCATCGGCAACATGCTGCTCATCGCCGGGCACGAGACGATCGCCAACACCCTCTCCTCCAGCATCGCGCTGCTGCTCCAGCACCCCGAGCAGCTCGCGGCCGTGCGCGACGACCCCTCGGTGACCGACAGCGCCGTGGAGGAGCTGCTGCGCTACATCGCCCCGGCCACCATCCTGCCGCGCCAGGCCGCCGGGGACATCTGCGTGCGCGACCAGGAGATCCACAAGGGCGAGCACGTCGTGCCGTCCGTGCTGGCCGCCAACCGCGACCTCGGCACCGCCGACCAGGACCTGGACAGCCTCGACGTGCGCCGCCCCGCGCAGCGCCACCTCACCTTCGGCTTCGGCCCGCACCAGTGCCTGGGCCAGCAACTGGCCCGCATGGAACTGCGGGTCGCGCTGCCCGCCCTGTTCACCAGGTTCCCCACGCTGCGCTCGGCGGTCCCGCTCGACGACCTGGAGTACCGCACCAACGCCCTGGTCTTCGGCGTCAACGCCCTGCCGGTCACCTGGTGA	MTEPKTVPIGGRAAQCPFAPVAELYDTQKEDELSRVKVPSPMLGEFDAVLVTRYDDVKDVLADEGLRMGGSMPYQPGNLLSYDGPEHTKLRRMLTASFTTKRARELRPGIEAVVASSLDAVEEAGPGADLVQLFSTPIPTLVICELLGVPYTDREGFQRRTALALDFTQSREVQMEKAAEMMAYMAQLVARHRENAGDNVLGRVVREYGDQLSDEELAGIGNMLLIAGHETIANTLSSSIALLLQHPEQLAAVRDDPSVTDSAVEELLRYIAPATILPRQAAGDICVRDQEIHKGEHVVPSVLAANRDLGTADQDLDSLDVRRPAQRHLTFGFGPHQCLGQQLARMELRVALPALFTRFPTLRSAVPLDDLEYRTNALVFGVNALPVTW	FTNIPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAINQEGELGIYDEMIPSYTIFHEDTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDIPENVFNVSMIPWSTFDSFNLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQV	237.20	gnl|BL_ORD_ID|960|hsp_num:0	1047			30	129	azidamfenicol; chloramphenicol; thiamphenicol
BGC0000665.1|Xiamycin_12 # 10906 # 11931 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.747	BGC0000665.1|Xiamycin_12 	10906	11931	-	Loose	1900	27.335	TriC	30.36	3003681	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGACGACGCCGGTCCCCGGCCTGACCGCGGTCCTCGACACCACCCGGACCCTCCTCGAACCCGCCCTGCGCGAGGCCGTCGCCACGCACCTGGGCCCGCAGATGAACAGGATCGCCCGCTACCACTTCGGCTGGTCCGACGCCGAGGGGCGCCCGACCGGTGCCTGGGGCGGCAAGATGATCCGGCCCAACCTGGCCCTGCTCTCGGCCCGCGCGGCCGGTGCCGAGGCCGAGGACGGACTGCCCGCCGCGGTCGCCATAGAACTCGTGCACAACTTCTCGCTGCTGCACGACGACATCATGGACGGCGACGAGACCCGGCGGGGCCGGGCCACCGCCTGGACCGTCTTCGGCGTGCCGGGCGCCATCCTGGCCGGTGACGCCCTGGTCGCCGCCGCGACGTGCGTCCTGCTGGCCGCACCGGCCGCGGGCGCCCGTTCCGCCACCCTGGCGCTGACGGCCGCGACCCGGCGGATGATCGACGGCCAGGCCGCCGACTCCGAGTTCGAGCGGCGCGAGGACGTGACCCTCGCCGAGTGCGTCCGCATGGCCGGCGACAAGACCGGCGCCCTGCTGGGCAGCGCCTGCGCGCTCGGCGCCGACCTGCAGGGCGCCGAACCGCGCCTGGTCGAACGGCTCGAAGCCTTCGGCGAGCACATCGGGCTCGCCTTCCAGCTCGTCGACGACCTGCTGGGCATCTGGGGCGAGTCCGCGCACACCGGCAAACAGGTGGGGGCCGACCTGCGGGTCCGCAAGAAGTCCCTGCCCGTGGTGGCGGCCCTGAACGCGCCCGGGACGGACGAGCTGCGCGCCCTGTACCTGCGACCGGAGCCGCTGACCGAACCCGACATCCGGCGGGTCACCACGCTCGTCGAACGGGCGGGCGGACGGGACTGGGCACAGAACGAGGCGGACCGGCAGATCGCCGCGGCCGAGGAGTGCCTGACCGCCGTCGACCTCCCGGACGACGTGCACCGCGCGTTCACGGAGGTCGCCGGGTTCGTCGTCGGCCGCCGCCTGTAG	MTTTPVPGLTAVLDTTRTLLEPALREAVATHLGPQMNRIARYHFGWSDAEGRPTGAWGGKMIRPNLALLSARAAGAEAEDGLPAAVAIELVHNFSLLHDDIMDGDETRRGRATAWTVFGVPGAILAGDALVAAATCVLLAAPAAGARSATLALTAATRRMIDGQAADSEFERREDVTLAECVRMAGDKTGALLGSACALGADLQGAEPRLVERLEAFGEHIGLAFQLVDDLLGIWGESAHTGKQVGADLRVRKKSLPVVAALNAPGTDELRALYLRPEPLTEPDIRRVTTLVERAGGRDWAQNEADRQIAAAEECLTAVDLPDDVHRAFTEVAGFVVGRRL	MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQMIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFRSEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEFGEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLRAGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELGDSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIVAVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFLMKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGAIRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPVGRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLGLSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIPLKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYRIEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAALLPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILLTAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR	33.60	gnl|BL_ORD_ID|2004|hsp_num:0	2194			2007	2175	triclosan
BGC0000665.1|Xiamycin_13 # 12059 # 14227 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.755	BGC0000665.1|Xiamycin_13 	12059	14227	-	Loose	760	31.9574	tet(X3)	25.71	3004719	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGACCTCCCCGAACTATGCGACGTATCTGCACCTCCCCGAACTGCTGGACCTCCAGCGCCCGTTGACACCGGTCGACCAGCAGGACCTCAGTGACAGCGAACGGCTCTTCATCGTCGTGCACCAGGCGTCCGAGACCCTGCTCAGCCAAGTGCTGGTCGACCTGCGGCACATCGCCTCCGGGCAGTGCGGACGGCGGTGCCACGACCGGCGCGCCCAGCGGGCGACGCGGCTGGTGGGCGCCCTGGAAGGACAGCTGAAGCTGCTGCACCACACGCTGCCGCGGGAGGACTTCCTGCTCTTCCGGCACCGGTTCGGCACGGCGAGCGGAGTGCAGTCGAAGCAGTTCCACGAACTGTTCGCCCGGGTGCGGAAGCTGACGAAGCACGGTGACGAGGACGGCCCCGCGGCCGATCCGGAGCTGCTGACGGCGCTGGACGAAGCCGTACGGCGCTGGCGGCACACCCACATCGAACTGGTCGCCCACATGCTCGGCGACCGGCCGGGCTCGGCCGAGACCTCCGGACTGCGCTGGCTGGCCGCCCGGCTGGACGGCAGCTCCGACACCGCCTCCTACACGGCCTCCTACGGCAGCTCCGGCACCATCTCCTACGGCAGCTCCGACACCGCTTCCGGCACCGCCTCCTACAACGCCGAACCGAGCGCCGCCGAACAGCAGGGCGCCTGCCCCGTGGCCGGGGGACGCCGGTCCACCGGGCAACAGGCCGCCGGACCCGAGGCCGAGGGCCCCCGGGCCACCGAACCCCCCACCGCCGAACGGCAACCCGTCACCGCGCCCCGGCGGGCCGCCGCAGCCGGCGGCCTCGGGCACGTGGTCGTCGTGGGCGGCAGCGTCGCGGGGCTGCTGACCGCGCACGTCCTGGCCGGCCACGCCGAACGGGTGACGGTGCTCGAACGCGACCAGTACGAGGACACTCCGGGCCCGCGCGCCGGGGTGCCCCAGTCGCGCCACACCCACGTCCTGCTCACCAGCGGCATGAACGCCCTGGAGGAACTGCTGCCCGGCCTGCTGCCCGCACTGGAGGACGCGGGGGCACCGCGGCTCGCGGTCCCCGGCGACCTCGGCGTGTGGCAGGCGGGCCAGTGGATATCGCGCCGCAACCCGTCCCGGCCGATCATGACCCCCTCCCGCCCGCTCCTGGAACACCACGTCCGCCGACGCGTCCTGGACGACCCCCGGGTCCACGTCCGCACCGGTGTCGAGGTGACCGGCCTGCTCGGCCGCCCCGGACACATCACCGGCGTCGCGGTCCGCACCCGCGGCGGCGACCACCCCGCCCGGCAGGAGATCGAGGCCGACCTCGTGGTGGACGCCTCCGGCCGGGCCAGCCGCACCCCCGCGTGGCTGGCCGACCTGGGCGCCCCGGCACCCGCCGAGGAACTCGTGGAGACCGGACGGGCCTACGCCACCTGCGTCTTCCACGCCGACCACCCGCCCGAGGACCTCGACGGCTTCTACATCGTCCCCGACGCCGGCCAGCCGCTCGGCGCGATCGTCCTGCCCGTCGAGGGCGACCGCTGGATGGTCACCCTGTCGGGGCCGCGCGGCGAGGCACCGCCCGGCGACGCCGAGGGCTTCGTCGAGTTCGCGGGCCGCCTGCCGCACTCCGCGCCGCACAAGTGGCTCCGCTCGGCACGCCCGGTCGGGCGGCCCGCGGGCTACCGGCACACCGCCAACCGGCGCCGCCGCTACGACCGCCCGGGGCAGCACAACACCGGACTGCTCGTCGTCGGGGACGCGGCGTGCGCGCTCAACCCCGTCTACGGACAGGGCCTGTCCGTCGCCGCCCTGAACGCGGTCGCCCTCCGCGAGGAACTGGCCGGGAAGCGCGCCGTCCCGTCCCGCACCCTGCAACGGGCGGTGTTCCGCTCCGCCCGCCGCGCCTGGGACGTCGCGACGGGCGCCGACAGCCCCATGCCGGGCGTCACCGGCAACGCGGTGCGCTCCGGGCCCGCCGCGCGGCTGCTGACCCGGTACCTCGACCGGGTGCGCGCGCACGTGCCCCACGACCCGGTCGTCTGCGGCACCCAGCGCGACGTCCTCTTCCTGCTGGCCCCGCCCCGCACGCTCGTCACCTCCCCCCGGGTGCTGCGGCGGGCCCTGCTGAGCCCGGCCGGGCCCGACCGGTCCGCGCCCCCCACTCCATGA	MTSPNYATYLHLPELLDLQRPLTPVDQQDLSDSERLFIVVHQASETLLSQVLVDLRHIASGQCGRRCHDRRAQRATRLVGALEGQLKLLHHTLPREDFLLFRHRFGTASGVQSKQFHELFARVRKLTKHGDEDGPAADPELLTALDEAVRRWRHTHIELVAHMLGDRPGSAETSGLRWLAARLDGSSDTASYTASYGSSGTISYGSSDTASGTASYNAEPSAAEQQGACPVAGGRRSTGQQAAGPEAEGPRATEPPTAERQPVTAPRRAAAAGGLGHVVVVGGSVAGLLTAHVLAGHAERVTVLERDQYEDTPGPRAGVPQSRHTHVLLTSGMNALEELLPGLLPALEDAGAPRLAVPGDLGVWQAGQWISRRNPSRPIMTPSRPLLEHHVRRRVLDDPRVHVRTGVEVTGLLGRPGHITGVAVRTRGGDHPARQEIEADLVVDASGRASRTPAWLADLGAPAPAEELVETGRAYATCVFHADHPPEDLDGFYIVPDAGQPLGAIVLPVEGDRWMVTLSGPRGEAPPGDAEGFVEFAGRLPHSAPHKWLRSARPVGRPAGYRHTANRRRRYDRPGQHNTGLLVVGDAACALNPVYGQGLSVAALNAVALREELAGKRAVPSRTLQRAVFRSARRAWDVATGADSPMPGVTGNAVRSGPAARLLTRYLDRVRAHVPHDPVVCGTQRDVLFLLAPPRTLVTSPRVLRRALLSPAGPDRSAPPTP	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL	186.08	gnl|BL_ORD_ID|4801|hsp_num:0	3401			915	1125	tigecycline; tetracycline
BGC0000665.1|Xiamycin_15 # 15358 # 18309 # -1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.775	BGC0000665.1|Xiamycin_15 	15358	18309	-	Loose	390	36.965	evgA	33.96	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCCCGAACGCGCGCCGCGGTGCGGGGCAGGGACCAGGAACTGACGGCGCTGCGCACCGCGCTGGCTCCCGACGGCGGACGCCTGATCGTCCTCACGGGCCCGGCCGGAATCGGCCGGACCGCGCTGCTGGACAGCGTCGCGCGGCTGCTGGCCGCGGACGGGGCGCGGGTCCTGCCGCTGCGGCTCGGCACCGGACCGGACGGCGGCGGTGACCCCTACGCCCTCGCCGCGCTGGTACGCGCCGTGCGTGAGCGGTTCGAGCAGTTGCAGGAGAGCGGGCTGAGCGAGGCGCTCAGCGCGGTGGCCCAACTGCGCGACGCACGAGGGCGGGAGAGAGGCGGCTGGACGCCGGCGGTGGTCGCCGCGCTGGACGGTCTGTTCGAGACCGTCGGCCGGCGGGAACGCGTCGCACTCCTCGTCGACGACGCGCACGCGGTGGCCGAGCCCGCGCCGGTGCTGAGCGCGGCCCGCCGGGCCGGCTGCCTGGTGGTGGCGACCTGCGAGGAGGGCGCCGAGCGCGGCCCGGGACTCGCCGAACTGCTGACCGACGCCGACCGGGTGATGACGATCGGTCCGCTCGCCGACGACGTCGCGCTGTCCCTGGTCCGCCGCGCGGCGGGAGCACGCCTCGACGAGTCGGTGGTGACCGCTCTGCGCACGGCGCTGGGGCCCCTCCTCGGCAACCCGGGCACCGTCCTCGGCACGCTCGACGCACTGCGCCGCAGCGGCCGCCTCGTCACCTTCGAGGGCCGGCTGTGCCTGAGCGATCCGGCCGAGCCGGTGGCGCTCCCGGCCGACCACCCGCTTCTGCGCCGCGCGTCCGCACTGGGCGGCACCGCGGTCCGGCTGCTGGGCGCGGTCGCGCTCCTGGACGGCCTCGATCTGGACGCCCTGCCACCGCTGGCCGACATCCTGGAGGCCGACCCCGTCGACTGCGGCCGGGGGCTCGACCTGCTGATCGAGGCGGGCGTGCTGACGGCCGGCCCGGACGGCCGGATCGCCTGCCGATGCCCGGCCCTGGCCGCCACCGCGGCCGGCCGCTTCCGCGCCCGCCGCGGCACCGCGCTGCACGCGGCGCTGGCGGAGCGACTGCTGGCCGGCCACCGGCGGTCCGGCGGCGTCGACCCCGTGGTGCTCGCCGACCACGTCGCGCGCGGCGGAGCGACCGTCACGCTCGACGACGACACGGTCCGGCAGCTGCTCACCATGGGCGCGGCCGCCGAGCAGGAGGAACCGGAGCGCGCCACCCTGTGGTACGCGGCCGCACTGCGCCGCCTGCCGCCGACCGGGCCCGAACACGCCCGCACCCTGTGCAGACTGCTCCTCCTGGTCGTCCGGACCGGCCGGTACGAGCTGCTGCGCGAGCCGCTGACCCGGTACGCGGAGCACGGCTGCGCGGAGGAGTCCGTGGACGAGATCCGCCTCGCCGCCATCCTCCTCGCCCTGCACAGCGGCGTACCGCCCGCCGAACGCGCCGTACGGGAACTGCTGGACGCGCCGTTCCCGGGCCGCGGGCCCACCGCCTTCTCGGAGTGGTGGTTCGACCGCCGCCTCGCCCCCGACCCACGCCGCCACCCGGCGACAGACGGCGACACGGTGGCCCGGTGCGGGTGCGGGTGCGGTGCGGTGCGGTGCGGTGCCGGTGCCGGTGCCGGTACGCGGGCCGGGCCGAGCCGCGGGGGTGGGCAGAAGTCACGGCAGAGGCCGGGGCGTGACGGCGGCGAGGCCGAGACTCCGGCTGGGGCAAGGCTTCGGTGGGGGGCGGTGCCGGTGACAGATCGGAGCCGAGCCGTAGCCCGGGACGGGACAGCCGCCGGGGACGGGGCGCGGGGCGGGGCCGGGCGGTCGGATCTGCTCAGCGCCGCGCTCTGCGGTGACGTCGCCGCATGCGAGCGGGTCTGGCGCAGCTCGGGCGGCGCCGCGCCCTCGCCCGAGTTGGACCGGGTTGCGCCAGGCCGCCTGGTCGCCGACATGGCCGACGTGGCCCGGCTGGTGATCGGCGCCGACTACCGGGTGCCGGAGACCGGTGTACTCGGCGCCTACCACCGGGTCGTGCGGGGCTACGCCGACGCCGACTGGACGCGGGCCATGTCCGCCGTACGGGAGCTGGAACTCTCCCCGGCCGAGGACACGCTGGCGCGCCACGCGGCGCGGCTGCTCGCCGTGGACATGTGCGCCGCCCGCGGCGAGTTCGGGCAGGCCTCCCGGTGGCTGACCGCGGCGACGCGGGCGCCCCGGCTCGCCGTGCTGCGCACCTGGGCGCGGGTCGGCCTGGCGGCGAGGAAGGGCGACGACGGCCAGGCGGTGCGGGTCGCGTTGCTGGCCGGACCGCGGCTGCGCCGGGCCGGGCTGCGCACCGGTCTGTCCATCCTGCTGTCGCGGGCGCTGCGGATCGCCGTACTCGGCGACGACCACGAGGGGGCCGCCGAACTGCTGGCGGAGATCGAGCTGTTGCCCCACGAGCACCACGTGGACGCGCAGGAGAGCCTGCTGCTGGCGCGGGGCCTGGTCCACCGCGACCCGGAGTGCGCCCGGGAGGCCACCGACCTGATCCGCGAGCGGGGCGACCTGCCCGCACTGATGGAGTCCTGCCTGGCCGTCGCCCGGTTCGCGCCCGACCCCCGGCCCTGGTTGCGCGAGGCCCACGCCCTGGCCACCCGGTGCGGCGCGGCGGCACTCCTCGAACGCGTCCGCGAGGTGACACGTGAGCGCGGGGTGCCCGCACCGCGCGCCCGCGGCCGGCGCGACGCCCTGGCCGTCACCGAGCAGCGGATCATCGAGCTGATCGGCGAGGGCCTGACGAACCGGCAGATCGCACTGCGCCTGCGGCTCAGCGAGAAGACCGTGGAGAACTACCTCACCCGCCTGTTCGCCCGCACCGGCTGCCGCTCGCGGGTCGAGCTGGCCGCGGCCAGCCTGACCGGCCGGCTCGCCCGGACCCCGACCTGA	MARTRAAVRGRDQELTALRTALAPDGGRLIVLTGPAGIGRTALLDSVARLLAADGARVLPLRLGTGPDGGGDPYALAALVRAVRERFEQLQESGLSEALSAVAQLRDARGRERGGWTPAVVAALDGLFETVGRRERVALLVDDAHAVAEPAPVLSAARRAGCLVVATCEEGAERGPGLAELLTDADRVMTIGPLADDVALSLVRRAAGARLDESVVTALRTALGPLLGNPGTVLGTLDALRRSGRLVTFEGRLCLSDPAEPVALPADHPLLRRASALGGTAVRLLGAVALLDGLDLDALPPLADILEADPVDCGRGLDLLIEAGVLTAGPDGRIACRCPALAATAAGRFRARRGTALHAALAERLLAGHRRSGGVDPVVLADHVARGGATVTLDDDTVRQLLTMGAAAEQEEPERATLWYAAALRRLPPTGPEHARTLCRLLLLVVRTGRYELLREPLTRYAEHGCAEESVDEIRLAAILLALHSGVPPAERAVRELLDAPFPGRGPTAFSEWWFDRRLAPDPRRHPATDGDTVARCGCGCGAVRCGAGAGAGTRAGPSRGGGQKSRQRPGRDGGEAETPAGARLRWGAVPVTDRSRAVARDGTAAGDGARGGAGRSDLLSAALCGDVAACERVWRSSGGAAPSPELDRVAPGRLVADMADVARLVIGADYRVPETGVLGAYHRVVRGYADADWTRAMSAVRELELSPAEDTLARHAARLLAVDMCAARGEFGQASRWLTAATRAPRLAVLRTWARVGLAARKGDDGQAVRVALLAGPRLRRAGLRTGLSILLSRALRIAVLGDDHEGAAELLAEIELLPHEHHVDAQESLLLARGLVHRDPECAREATDLIRERGDLPALMESCLAVARFAPDPRPWLREAHALATRCGAAALLERVREVTRERGVPAPRARGRRDALAVTEQRIIELIGEGLTNRQIALRLRLSEKTVENYLTRLFARTGCRSRVELAAASLTGRLARTPT	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	481.86	gnl|BL_ORD_ID|936|hsp_num:0	1015			423	582	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000665.1|Xiamycin_16 # 18554 # 21259 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.755	BGC0000665.1|Xiamycin_16 	18554	21259	+	Loose	400	33.113	salE	24.66	3007029	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	GTGGCGCACGTCGCCGAGCTGGCCGTCTCGTCGGACGCGGCGCCGCTCGTCCTGGTCACCGGCCCCATCGGCATGGGACGCAGCTCGCTGCTGGCCGCGGTCCGGGCCGAGTTGACCGCGAGGGGGTTCACTCCCCTGTCGCTGCGGGTGGCACGCAACGAACGCGACCGTCCCTACTCCCTCGCCTCCCGCCTCTGCGCCGAGATCGCCGCGCTCCGGAGCGGTGACGCCAGGCGTACGGCGCGGGCCACGGCCGTGGTGTCCCTCGGCGAGGCGGGCCGGCAGCTCGCCGCCGAGCTGCGGTCGGCCCTCACCGTGAACGACAAGCTGACGGTGCTGATCGACGACGCGCACTGGGCCGACCCCGCGTCGCGCGCCGTGCTGCTGTCGCTCACCCGCGCGCTGGCGGGCGGCCCGGTCACCGTCGTCTGCACGGTGCGCCCCTCACCGGCCGATCCGGCGAGCGAGCGGGCCGTGCTGGAGCAGCTGCGGGCCGCCTCGCTCGCCGAGGTGGTGCCGCTTCGCCCGCTGGGCGAGCAGGAGGTGGCTGCGCTGATCGCCCACACCCTGCAGGCCAGGCCGACGGCCGCGCTGCTGTCCAGTCTGCAGCGGGAGTGCCGGGGCAGGCCCGCCGCCGTGCTCGCGGCCGTGGCGGGGCACCTGCGCACCGGCGGACTTCAGGTGTACGACCGGCACGTGTACCTCACGTCGCCGGACCGGCCGCCCGAACTGCCCCTCGACCTGCCGCCGATCGAGTATCTGCGCCGGCTGGGCGGAACGGTCTGGGCGGTGGCCAAGGCGGCGGCGGTCATGCTCCCGCTGGGCACCGCGGCCACCGGGCTGATCGCCCGGGCGGTGGGCCGGGACGAGGAGGAGGTCCGGGGCGCGCTGTCGGAGCTGTCCGTGGAGGGCGTGCTGCGGCAGGAGACCGAGGACGGGCGGTGGCGCTTCCGGCTGCCGCTGCTCGCCTCCGCCCTGACCGGCTGCCTCGGCCCCTGGGAGCGGCGCAGCCTGGCCCGGCTGGCGGTCACCGCGATCTGGGCGGGCGACGCCGTGGCGGACGACCGCTACCTGGCCGATCAACTGGTCGTCGCGGGGCGCTCCGTGGACGCCCGGCGGGCCGCCGGTGAACTGCTCGCCCGGGGCACCGCGGCGATGCTGGACGACGGGTACTGTGCGGAACGCTGGCTGCGCGCCGCCGCCGAGCTGGCCACGGAGCCGCGGCAGCGCGCCCGGGTGCTGGTCGCCCACGCCACCACCTGCTGCCTGCAACTGCGCTTCGCCGAGGCGATCGACAGCGCGGGGAAGGTCTTGTCCGAGTACGCGGAGGACCACGTCGACTCCGCGACGCTGCTGGAGATCCAGCTGGCGTACGTCGTCGCACTGGCCGGAACCCTGGACACCGCCGCGCTCACCGAGCTGTGCGACGGTGGCTGGCGCTCGCTGCCGGGCAGGCAGTGGCATCGCGTGGTGACCCGGTGCATCGCCCTGTGCCACCTGGACCGGTGGCGGGAGGCGGACGAGCACCTGGCACTCCTGCGGCACGTCTGGCATCGGGACGACGACGTCTTCGCCGGGCTCGGGCTGCTCGTCAGCGAGTGCACCGGAGCGTACATGGGCCGCTTCGAACCGTTCGAGCAGGCCGTCGCCGACCCGACCGACTGGCCCCTGTGGGCCTCGGGGCCCCGCTTCCGCTTCGAGCGGCTGTGGCAGCTGGCCCGGGTGCTGATGGCCTTCGGCGAACAGGAGCGCGCGGACCGGCTGCTGGCGGCCCACGACCCGCCCTCCGCCTACCGGACGCTGCCCGACCAGGTGGTGGCCGACAGCCAGAGCGGGCACTGGGACCGCGCCCTCGACACGGCCCGGCTCGGCCTGGCCACCGGTCTGTCCGTCGGCTACGCGCCCAGCCACACCCTGGTGTCCCGGGAGACGAGCGTGATACTCGGTGCGCGCGGGCGGCTCACCGAGGCCCGCGCGGTGATCGAGCGGGCGCGTTCCGTGCAGCCGGTGATGCTGCACCTGCTGGCCGTGGCGGAATCGTGCCTGGACGAGGCCCTGGGGGACGTCGAAGGCGCCCTCGACGTCGTCGCCCGGGGGCTGGCCCTGGCCGCCGACCGGGGTCTGGTGGTCGGCACGGACGTCCTGTGGCTGAGGTCGGCGGGGCTGGAACTGGCCCGCGGCGACCGCGCCGCGGCACGGCGGGCCGTGGCGGAGACCGGCCGGACGGCCGAGCTGACCGGCACCGGCCGGGCCCGCCTGTGCCATCTGCTCGCCACCGCGACCGTGGAGGGCGACCGGGCCGCCGCGGCGGAGGCGATCGGACTCGCCCGGCAGCGCGCGCAGCCGCTGGAGCTGGCCGACACGCTGACCCTGGCGGTCCGCCACGAGGTGGCCGACTCCGGGCTGCTGCACGAGGCGTACGCGCTCTACGGCGGCCTGGACGCGCTGCTGCGCAGGGCGCAGCTGCGCAACCTGATGCGCGCACGGGGCGTCACCGTGCCGCACAGGGCGGTCGTCACCGCGGAGAACGAGCGGCTCCTTGCCACCTTGGTGACCGAGGGGCTGACCAACCGCGAACTCGCCGCCGCGCTGGGCAGCAGCGAGAAGAGCGTGGAGAGCCGGCTGGGCAGGCTCTTCAAACGTACCGGCTACCGTTCCCGGGTCGAGCTGGCCTCCGCGATGCTGACGGACGACTACCGGGCCTGA	MAHVAELAVSSDAAPLVLVTGPIGMGRSSLLAAVRAELTARGFTPLSLRVARNERDRPYSLASRLCAEIAALRSGDARRTARATAVVSLGEAGRQLAAELRSALTVNDKLTVLIDDAHWADPASRAVLLSLTRALAGGPVTVVCTVRPSPADPASERAVLEQLRAASLAEVVPLRPLGEQEVAALIAHTLQARPTAALLSSLQRECRGRPAAVLAAVAGHLRTGGLQVYDRHVYLTSPDRPPELPLDLPPIEYLRRLGGTVWAVAKAAAVMLPLGTAATGLIARAVGRDEEEVRGALSELSVEGVLRQETEDGRWRFRLPLLASALTGCLGPWERRSLARLAVTAIWAGDAVADDRYLADQLVVAGRSVDARRAAGELLARGTAAMLDDGYCAERWLRAAAELATEPRQRARVLVAHATTCCLQLRFAEAIDSAGKVLSEYAEDHVDSATLLEIQLAYVVALAGTLDTAALTELCDGGWRSLPGRQWHRVVTRCIALCHLDRWREADEHLALLRHVWHRDDDVFAGLGLLVSECTGAYMGRFEPFEQAVADPTDWPLWASGPRFRFERLWQLARVLMAFGEQERADRLLAAHDPPSAYRTLPDQVVADSQSGHWDRALDTARLGLATGLSVGYAPSHTLVSRETSVILGARGRLTEARAVIERARSVQPVMLHLLAVAESCLDEALGDVEGALDVVARGLALAADRGLVVGTDVLWLRSAGLELARGDRAAARRAVAETGRTAELTGTGRARLCHLLATATVEGDRAAAAEAIGLARQRAQPLELADTLTLAVRHEVADSGLLHEAYALYGGLDALLRRAQLRNLMRARGVTVPHRAVVTAENERLLATLVTEGLTNRELAAALGSSEKSVESRLGRLFKRTGYRSRVELASAMLTDDYRA	MSFYFAQKPFEMFGKTLIQSVDLQFEKGEHIAVIGNNGVGKTTLLKALNNKYKEDTYLMDQNMTTFGNMTGIDYVISLNTELFHLKQALMDNYEKVSDYIALNGYEFEQTIITKAKQMALTEADLDKPIKVLSGGQQTRLALLRAFISNKPLILLDEPTNHLDQEMIDQLINHIQQSKRTIIYVSHHRGFIDQTASHVIEITPESTRKFNGNYKQYKEIKDLESQTEQRIYNKQQKEIQDLERTIKRVQTWHHSAQQKASVRNPIEQKKLSKLAQRAKVKEKQLNQKLQEKHIQEPSKETKSYYFSHQTSLPKRFLIRFEDVSVNIDGQAIYKHAHFEMKQNENILLTGPNGSGKSLFIALIRQHLSPDEGIIEITPSLKIGYFDHTNNNLNEAESPLSMLLVRTNITRSQAQTLLASFNFDKDQIKKPIRYLSMGEKSRLQFVLLYFSGANLLVLDEPTNYFDIVTQDLILSMIQSFTGQVLIVTHDSYLQSQFKAVHWEIKNQQLYNVSLTHTRESNLDETLKLLGEYKFIDENGHFETDN	165.93	gnl|BL_ORD_ID|4728|hsp_num:0	5740			1032	1455	tiamulin; retapamulin
